Overview


According to FutureWise analysis, the market for African Horse Sickness Treatment is estimated to be US$ 0.84 billion in 2023 and is expected to reach US$ 2.98 billion by 2031 at a CAGR of 17.20% over the forecast period of 2023-2031.

African horse sickness (AHS) is a profoundly contagious and frequently lethal ailment triggered by the African horse sickness virus. The disease can manifest via any of the nine serotypes affiliated with this virus. Although not transmitted directly between animals, AHS is disseminated through insect vectors. African horse sickness (AHS) primarily affects horses, mules, donkeys, and zebras. Although elephants, camels, and dogs can also contract the disease, they rarely show symptoms, often through ingesting infected horse meat. AHS spreads through insect vectors, particularly Culicoides midges, mosquitoes like Culex, Anopheles, and Aedes (including A. aegypti), and certain tick species such as Hyalomma and Rhipicephalus.

AHS presents in different forms: the peracute form with high fever and severe respiratory issues, often fatal within 24 hours; the subacute cardiac form marked by fever, conjunctivitis, abdominal pain, and edema, resulting in a 50-70% mortality rate; a mild or fever form observed in zebras and African donkeys with low-grade fever and congested mucous membranes; and a mixed form displaying characteristics of both pulmonary and cardiac types, typically fatal. Diagnosis involves clinical signs, post-mortem examination, and vector presence. Laboratory confirmation employs viral isolation, quantitative PCR, antigen capture, and immunofluorescence. No specific AHS treatment is available. Controlling outbreaks necessitates quarantine, vector management, and vaccination. Vaccines include polyvalent, monovalent, and monovalent inactivated options. Combating AHS involves eliminating vector habitats and utilizing insecticides.

FutureWise Market Research has published a report that provides an insightful analysis of African Horse Sickness Treatment Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts’ projects that African Horse Sickness Treatment Market will experience a significant growth.

According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Onderstepoort Biological Products SOC Ltd.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Development in African Horse Sickness Treatment Market:

  • Having obtained FDA approval in October 2021, Boehringer Ingelheim is preparing for the market release of its newly developed vaccine, Cyltezo Pen, which is projected to be accessible to the public starting in July 2023. 

Increasing investments in research and development to provide preventive vaccinations are poised to drive global market growth. Companies are investing heavily in R&D to align with authoritative species health recommendations and develop new treatments for AHS, fueling the expansion of the African horse sickness treatment market. Rising per capita income enables significant spending on horse-related activities, propelling market growth. The expanding population of African equestrians, facilitated by enhanced transportation and healthcare infrastructure, further bolsters the global market's trajectory. Modernization and urbanization drive increased healthcare spending, broadening the market scope. Heightened awareness about early AHS diagnosis and treatment also contributes to market growth.

However, lack of awareness hinders market growth, with people often managing AHS symptoms through local or clinical remedies. On the other hand, a surge in demand for horse meat, particularly in Africa, presents promising opportunities. Nonetheless, the substantial cost of healthcare services poses a challenge, restricting access to medication courses and diagnostics for many, thereby impacting the global market.

By Clinical Forms of The Disease

  • Pulmonary Form or “Dunkop”
  • Cardiac Form or “Dikkop”
  • Mixed Form
  • Horse Sickness Fever

By Diagnosis of the Disease And Prevention Strategies

  • Diagnosis Tests
    • Laboratory Tests for Viral Antigens
    • Enzyme-linked Immunosorbent Assays (ELISA)
    • Reverse-transcription PCR Assays
  • Serological Tests
    • Prevention Treatment
    • Vaccines

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America's African horse sickness treatment market dominance stems from heightened awareness, advanced healthcare technology, strong market players, and updated guidelines. Asia Pacific displays steady growth driven by a burgeoning healthcare sector and a rise in pharmaceutical firms, with India, South Korea, and Japan as key players. Europe anticipates significant expansion due to increased awareness, novel drug introductions, and more significant pharmaceutical investments in research and development for enhanced global competitiveness.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the of African Horse Sickness Treatment Market By Clinical Forms of The Disease, By Diagnosis of the Disease and Prevention Strategies and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represents in format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1 . Years Considered for the Study
         3.2 . Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1 . Secondary Data
          1.1.1 . Key Data from Secondary Sources
         1.2 . Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   African Horse Sickness Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of African Horse Sickness Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   African Horse Sickness Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   African Horse Sickness Treatment Market, By Clinical Forms of The Disease Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Pulmonary Form or “Dunkop”
        2. Cardiac Form or “Dikkop”
        3. Mixed Form
        4. Horse Sickness Fever

  • 8.   African Horse Sickness Treatment Market, By Diagnosis of the Disease And Prevention Strategies Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Diagnosis Tests
         1.1. Laboratory Tests for Viral Antigens
         1.2. Enzyme-linked Immunosorbent Assays (ELISA)
         1.3. Reverse-transcription PCR Assays
        2. Serological Tests
         2.1. Prevention Treatment
         2.3. Vaccines

  • 9.   North America African Horse Sickness Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America African Horse Sickness Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe African Horse Sickness Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific African Horse Sickness Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa African Horse Sickness Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Saudi Arabia
         2.2. UAE
         2.3. South Africa
         2.4. Egypt
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Onderstepoort Biological Products SOC Ltd.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 17.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients